Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Targeting patient recovery priorities in degenerative cervical myelopathy: design and rationale for the RECEDE-Myelopathy trial-study protocol.
BMJ Open. 2023 Mar 7;13(3):e061294. doi: 10.1136/bmjopen-2022-061294.
BMJ Open. 2023.
PMID: 36882259
Free PMC article.
Rationale and study design of the Adaptive study of IL-2 dose on regulatory T cells in type 1 diabetes (DILT1D): a non-randomised, open label, adaptive dose finding trial.
Waldron-Lynch F, Kareclas P, Irons K, Walker NM, Mander A, Wicker LS, Todd JA, Bond S.
Waldron-Lynch F, et al. Among authors: kareclas p.
BMJ Open. 2014 Jun 4;4(6):e005559. doi: 10.1136/bmjopen-2014-005559.
BMJ Open. 2014.
PMID: 24898091
Free PMC article.
Clinical Trial.
Item in Clipboard
Protocol of the adaptive study of IL-2 dose frequency on regulatory T cells in type 1 diabetes (DILfrequency): a mechanistic, non-randomised, repeat dose, open-label, response-adaptive study.
Truman LA, Pekalski ML, Kareclas P, Evangelou M, Walker NM, Howlett J, Mander AP, Kennet J, Wicker LS, Bond S, Todd JA, Waldron-Lynch F.
Truman LA, et al. Among authors: kareclas p.
BMJ Open. 2015 Dec 8;5(12):e009799. doi: 10.1136/bmjopen-2015-009799.
BMJ Open. 2015.
PMID: 26646829
Free PMC article.
Clinical Trial.
Item in Clipboard
A phase 2 study of vatalanib in metastatic melanoma patients.
Cook N, Basu B, Biswas S, Kareclas P, Mann C, Palmer C, Thomas A, Nicholson S, Morgan B, Lomas D, Sirohi B, Mander AP, Middleton M, Corrie PG.
Cook N, et al. Among authors: kareclas p.
Eur J Cancer. 2010 Oct;46(15):2671-3. doi: 10.1016/j.ejca.2010.07.014. Epub 2010 Aug 25.
Eur J Cancer. 2010.
PMID: 20800475
Clinical Trial.
Item in Clipboard
Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma (COUGAR-02): an open-label, phase 3 randomised controlled trial.
Ford HE, Marshall A, Bridgewater JA, Janowitz T, Coxon FY, Wadsley J, Mansoor W, Fyfe D, Madhusudan S, Middleton GW, Swinson D, Falk S, Chau I, Cunningham D, Kareclas P, Cook N, Blazeby JM, Dunn JA; COUGAR-02 Investigators.
Ford HE, et al. Among authors: kareclas p.
Lancet Oncol. 2014 Jan;15(1):78-86. doi: 10.1016/S1470-2045(13)70549-7. Epub 2013 Dec 10.
Lancet Oncol. 2014.
PMID: 24332238
Free article.
Clinical Trial.
Item in Clipboard
Decompressive Craniectomy versus Craniotomy for Acute Subdural Hematoma.
Hutchinson PJ, Adams H, Mohan M, Devi BI, Uff C, Hasan S, Mee H, Wilson MH, Gupta DK, Bulters D, Zolnourian A, McMahon CJ, Stovell MG, Al-Tamimi YZ, Tewari MK, Tripathi M, Thomson S, Viaroli E, Belli A, King AT, Helmy AE, Timofeev IS, Pyne S, Shukla DP, Bhat DI, Maas AR, Servadei F, Manley GT, Barton G, Turner C, Menon DK, Gregson B, Kolias AG; British Neurosurgical Trainee Research Collaborative, NIHR Global Health Research Group on Acquired Brain and Spine Injury, and RESCUE-ASDH Trial Collaborators; RESCUE-ASDH Trial Collaborators.
Hutchinson PJ, et al.
N Engl J Med. 2023 Jun 15;388(24):2219-2229. doi: 10.1056/NEJMoa2214172. Epub 2023 Apr 23.
N Engl J Med. 2023.
PMID: 37092792
Clinical Trial.
Item in Clipboard
Protection of erythrocytes from human complement-mediated lysis by membrane-targeted recombinant soluble CD59: a new approach to PNH therapy.
Hill A, Ridley SH, Esser D, Oldroyd RG, Cullen MJ, Kareclas P, Gallagher S, Smith GP, Richards SJ, White J, Smith RA, Hillmen P.
Hill A, et al. Among authors: kareclas p.
Blood. 2006 Mar 1;107(5):2131-7. doi: 10.1182/blood-2005-02-0782. Epub 2005 Dec 1.
Blood. 2006.
PMID: 16322479
Free article.
Item in Clipboard
Cite
Cite